Lazzari G, Benevento I, D’Andrea B, Prudente A, Brucoli I, Bianculli A, Tucciariello R, Lerose R, Metallo V, Solazzo A, Montagna A. The Impact of KEYNOTE-522 Related Immune-Related Adverse Events on Concurrent Adjuvant Whole Breast Radiotherapy in the Real World: A Case Series: KEYNOTE-522 and adjuvant hypofractionated RT. Arch Breast Cancer [Internet]. 2025 Apr. 21 [cited 2025 Apr. 24];12(2):231-5. Available from: https://archbreastcancer.com/index.php/abc/article/view/1088